Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities.

Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities.
复制标题

PDGF参与纤维化和硬皮病:动物模型的最新见解和潜在的治疗机会。

DOI:
10.1007/s11926-012-0304-0
复制
发表时间:
2013-03
影响因子:
5
通讯作者:
Olson LE
Olson LE
中科院分区:
医学2区
文献类型:
--
作者:
Iwayama T;Olson LE

文献摘要

参考文献

被引文献

相似文献

纤维化是称为硬皮病或系统性硬化症(SSc)的自身免疫性疾病的主要特征。过去三年发表的研究表明,血小板源性生长因子(PDGFs)在SSc相关纤维化中发挥着重要作用。PDGF也可能参与Ssc相关的自身免疫和血管病变。PDGF信号传导途径已被充分理解,并且PDGF受体在胶原分泌成纤维细胞和间充质干细胞和/或祖细胞上表达,其可能以深刻和意想不到的方式影响SSc。虽然在我们完全了解PDGF如何参与SSc之前还有很多工作要做,但使用PDGF抑制剂作为SSc的治疗方法有很大的兴趣。
Fibrosis is the principal characteristic of the autoimmune disease known as scleroderma or systemic sclerosis (SSc). Studies published within the last three years suggest central involvement of platelet-derived growth factors (PDGFs) in SSc-associated fibrosis. PDGFs may also be involved in SSc-associated autoimmunity and vasculopathy. The PDGF signaling pathway is well understood and PDGF receptors are expressed on collagen-secreting fibroblasts and on mesenchymal stem and/or progenitor cells that may affect SSc in profound and unexpected ways. Although much work remains before we fully understand how PDGFs are involved in SSc, there is much interest in using PDGF inhibitors as a therapeutic approach to SSc.
DOI: 10.1073/pnas.0409722102
发表时间: 2005-03-01
影响因子: 11.1
作者:
Campbell, JS;Hughes, SD;Fausto, N
通讯作者: Fausto, N
DOI: 10.1038/ng1415
发表时间: 2004-10-01
期刊: NATURE GENETICS
影响因子: 30.8
作者:
Ding, H;Wu, XL;Nagy, A
通讯作者: Nagy, A
DOI: 10.1002/art.34354
发表时间: 2012-06-01
影响因子: --
作者:
Kavian, Niloufar;Servettaz, Amelie;Batteux, Frederic
通讯作者: Batteux, Frederic
DOI: 10.1016/0014-4827(74)90484-4
发表时间: 1974-01-01
影响因子: 3.7
作者:
KOHLER, N;LIPTON, A
通讯作者: LIPTON, A
DOI: 10.1038/ncb2015
发表时间: 2010-02
影响因子: 21.3
作者:
Joe AW;Yi L;Natarajan A;Le Grand F;So L;Wang J;Rudnicki MA;Rossi FM
通讯作者: Rossi FM